A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting-Reference-Cited by-同舟云学术

A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting

Published:2022-11-23 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

van Maurik Ingrid S.¹²³⁴^ORCID,Broulikova Hana M.⁵,Mank Arenda¹²³⁴,Bakker Els D.¹²,de Wilde Arno¹²⁶,Bouwman Femke H.¹²,Stephens Andrew W.⁷,van Berckel Bart N. M.⁸,Scheltens Philip¹²⁶,van der Flier Wiesje M.¹²³⁴

Affiliation:

1. Alzheimer Center Amsterdam, Neurology Vrije Universiteit Amsterdam Amsterdam UMC location VUmc Amsterdam the Netherlands

2. Amsterdam Neuroscience Neurodegeneration Amsterdam the Netherlands

3. Amsterdam UMC location Vrije Universiteit Amsterdam Epidemiology and Data Science Amsterdam the Netherlands

4. Amsterdam Public Health Methodology Amsterdam the Netherlands

5. Department of Health Sciences Faculty of Science Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute Amsterdam the Netherlands

6. EQT Life Sciences Amsterdam the Netherlands

7. Life Molecular Imaging GmbH BerlinGermany

8. Department of Radiology and Nuclear Medicine Vrije Universiteit Amsterdam, Amsterdam UMC Amsterdam the Netherlands

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12846

Reference32 articles.

1. Diagnostic Accuracy of Amyloid versus 18 F‐Fluorodeoxyglucose Positron Emission Tomography in Autopsy‐Confirmed Dementia

2. Amyloid PET imaging in clinical practice

3. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

4. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

5. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of Ancillary Diagnostic Tests With Outcome in Dementia;Journal of the American Medical Directors Association;2024-07

2. Use of a Blood Biomarker Test Improves Economic Utility in the Evaluation of Older Patients Presenting with Cognitive Impairment;Population Health Management;2024-06-01

3. Use of a digital tool to support the diagnostic process in memory clinics–a usability study;Alzheimer's Research & Therapy;2024-04-08

4. Focusing on earlier diagnosis of Alzheimer's disease;Future Neurology;2024-03-20

5. Les phases prodromique et préclinique de la maladie d’Alzheimer;Pratique Neurologique - FMC;2024-03